Safety of a modified environmental rush immunotherapy protocol in the pediatric population
Ann Allergy Asthma Immunol
.
2022 May;128(5):600-601.
doi: 10.1016/j.anai.2021.12.011.
Epub 2021 Dec 16.
Authors
Christopher H Chu
1
,
Jason W Caldwell
1
,
Leslie M Cristiano
1
,
Andrej A Petrov
2
,
Russell S Traister
3
Affiliations
1
Section of Pulmonary, Critical Care, Allergy, and Immunologic Diseases, Wake Forest Baptist Health, Winston Salem, North Carolina.
2
Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
3
Allergy Division, Department of Pediatrics, Allegheny Health Network, Pittsburgh, Pennsylvania. Electronic address: russell.traister@ahn.org.
PMID:
34921984
DOI:
10.1016/j.anai.2021.12.011
No abstract available
MeSH terms
Allergens*
Child
Desensitization, Immunologic* / adverse effects
Desensitization, Immunologic* / methods
Humans
Immunotherapy / methods
Substances
Allergens